Inc. ("a.s.ist") leverages research expertise cultivated at The University of Tokyo to drive digital transformation (DX) in manufacturing through white-box AI.
The FDA's move to incorporate Bayesian statistical methods into clinical trials of drugs and biologics garnered special treatment in JAMA this week. JAMA published three perspectives -- two welcoming ...
The ability to make adaptive decisions in uncertain environments is a fundamental characteristic of biological intelligence. Historically, computational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results